Preclinical Safety Evaluation of Potentised Ethanolic Dilutions of <i>Bryonia alba</i>: An Acute and Subacute Oral Toxicity Study in Wistar Rats
Bryonia alba (B. alba) potentised ethanolic dilutions used in the homoeopathic system of medicine have potential immunomodulatory and antioxidant properties effective against viral infections, evidenced by clinical reports. However, data on its safety are unavailable, which has given impetus to carry out acute and subacute toxicity evaluations of ethanolic dilutions that have been homoeopathically potentised, particularly B. alba at 6C, 30C, and 200C. In the acute oral toxicity study, a 2000 µL/kg dose of B. alba potentised dilutions was administered to Wistar albino rats, and their behaviour and mortality were monitored for 14 days. In the subacute study, the animals were administered a daily dose of 200 µL/kg for 28 days and monitored for clinical signs and changes in body weight, followed by the evaluation of biochemical, haematological, organ weight, and histopathological parameters. In the acute oral toxicity study, no mortality was reported in the rats throughout the study, indicating that a single dose of 2000 µL/kg of B. alba is safe. Compared to the normal control group, no changes in the aforementioned parameters were found during the 28-day sub-acute investigation at a dose of 200 µL/kg/day. Based on these findings, no observed adverse effect level of B. alba - 6C, 30C, and 200C potentised dilutions was established as greater than 200 µL/kg/day. These findings support the use of potentised B. alba dilutions in future pharmacological and clinical research, showing that they are safe under the conditions evaluated. Major Findings: The study demonstrated that potentised ethanolic dilutions of B. alba (6C, 30C, and 200C) showed no toxicity in Wistar rats at doses up to 2000 μL/kg (acute) and 200 μL/kg/day (subacute). No mortality, behavioral changes, or significant alterations in biochemical, haematological, or histopathological parameters were observed, indicating a favorable safety profile.